Table 3.
No inflammation on CSF Exam (n=11) |
Intrathecal inflammation on CSF Exam (n=10) |
||
---|---|---|---|
Demographics | |||
Age in years, mean (SD) | 42.5 (15.8) | 33.8 (12.0) | |
Sex (%female) | 36.4% | 70% | ns |
Radiographic Features | |||
Lesion Number | |||
Solitary n(%) | 5 (45.5%) | 1 (10%) | P=0.15 |
Multifocal n(%) | 6 (54.5%) | 9 (90%) | |
Spinal Lesions n(%) | 2 (22.2%) | 3 (30%) | ns |
Treatment | |||
DMT n(%) | 6 (66.7%) | 8 (100%) | ns |
Prognosis | |||
Median follow-up in months | 19.5 | 47 | P=0.08 |
Clinical Relapse n(%)# | 2/8 (25%) | 4/6 (66.7%) | ns |
MRI Progression n(%) | 3/9 (33.3%) | 4/6 (66.7%) | ns |
Last EDSS, mean (SD) | 2.8 (2.3) | 4 (2.6) | ns |
Patients with available follow-up.